Literature DB >> 33904857

Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.

Lucie Renoud1, Charles Khouri1,2,3, Bruno Revol1,3, Marion Lepelley1, Justine Perez1, Matthieu Roustit2,3, Jean-Luc Cracowski1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33904857      PMCID： PMC8080152          DOI： 10.1001/jamainternmed.2021.2219

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  39 in total

1.  Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.

Authors:  Carlos King Ho Wong; Kristy Tsz Kwan Lau; Xi Xiong; Ivan Chi Ho Au; Francisco Tsz Tsun Lai; Eric Yuk Fai Wan; Celine Sze Ling Chui; Xue Li; Esther Wai Yin Chan; Le Gao; Franco Wing Tak Cheng; Sydney Chi Wai Tang; Ian Chi Kei Wong
Journal:  PLoS Med       Date:  2022-06-21       Impact factor: 11.613

2.  Signaling COVID-19 Vaccine Adverse Events.

Authors:  Rave Harpaz; William DuMouchel; Robbert Van Manen; Alexander Nip; Steve Bright; Ana Szarfman; Joseph Tonning; Magnus Lerch
Journal:  Drug Saf       Date:  2022-06-23       Impact factor: 5.228

Review 3.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 4.  COVID-19 vaccine development: milestones, lessons and prospects.

Authors:  Maochen Li; Han Wang; Lili Tian; Zehan Pang; Qingkun Yang; Tianqi Huang; Junfen Fan; Lihua Song; Yigang Tong; Huahao Fan
Journal:  Signal Transduct Target Ther       Date:  2022-05-03

5.  The association between COVID-19 vaccination and Bell's palsy.

Authors:  Nicola Cirillo; Richard Doan
Journal:  Lancet Infect Dis       Date:  2021-08-16       Impact factor: 25.071

6.  Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

Authors:  Nicola P Klein; Ned Lewis; Kristin Goddard; Bruce Fireman; Ousseny Zerbo; Kayla E Hanson; James G Donahue; Elyse O Kharbanda; Allison Naleway; Jennifer Clark Nelson; Stan Xu; W Katherine Yih; Jason M Glanz; Joshua T B Williams; Simon J Hambidge; Bruno J Lewin; Tom T Shimabukuro; Frank DeStefano; Eric S Weintraub
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

7.  Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.

Authors:  Reid McMurry; Patrick Lenehan; Samir Awasthi; Eli Silvert; Arjun Puranik; Colin Pawlowski; A J Venkatakrishnan; Praveen Anand; Vineet Agarwal; John C O'Horo; Gregory J Gores; Amy W Williams; Andrew D Badley; John Halamka; Abinash Virk; Melanie D Swift; Katie Carlson; Deeksha Doddahonnaiah; Anna Metzger; Nikhil Kayal; Gabi Berner; Eshwan Ramudu; Corinne Carpenter; Tyler Wagner; Ajit Rajasekharan; Venky Soundararajan
Journal:  Med (N Y)       Date:  2021-07-01

8.  Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses.

Authors:  Abigail Burrows; Theo Bartholomew; James Rudd; David Walker
Journal:  BMJ Case Rep       Date:  2021-07-19

9.  Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).

Authors:  Laure-Hélène Préta; Adrien Contejean; Francesco Salvo; Jean-Marc Treluyer; Caroline Charlier; Laurent Chouchana
Journal:  Br J Clin Pharmacol       Date:  2022-02-28       Impact factor: 3.716

10.  Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study.

Authors:  Zhi-Qiang Lin; Jiang-Nan Wu; Rong-Dong Huang; Fang-Qin Xie; Jun-Rong Li; Kui-Cheng Zheng; Dong-Juan Zhang
Journal:  Vaccines (Basel)       Date:  2022-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.